Skip to main content
Premium Trial:

Request an Annual Quote

Microfluidics Firm Dolomite Licenses IP from Japan Science and Technology Agency


Microfluidics firm Dolomite said this week that it has licensed microdroplet generation technology from the Japan Science and Technology Agency.

Under the agreement, Royston, UK-based Dolomite has a license to JST's microdroplet generation patent families including WO 2002/068104, entitled "Process for producing emulsion and microcapsules and apparatus therefor;" and WO 2005/089921, "Method and device for producing micro-droplets."

Dolomite said that the license authorizes it to grant sub-licenses to the technology, and that its customers may now purchase and freely use Dolomite droplet chips for R&D purposes.

The company offers a wide range of droplet-forming devices featuring different junction geometries, channel sizes, and surface properties for use in applications such as compartmentalized chemistry, single-cell analysis, high-throughput screening, droplet PCR, and emulsion studies.

Earlier this year, Dolomite announced a collaboration with San Francisco-based startup GigaGen to develop droplet merger chips for GigaGen's Cell-Seq platform for massively parallel single-cell genetic analyses using highly multiplexed PCR and next-generation sequencing (PCR Insider, 2/23/2012).

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.